Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to $1.2 billion.

  • Select Medical Holdings' Cost of Revenue rose 706.93% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 billion, marking a year-over-year increase of 663.48%. This contributed to the annual value of $4.6 billion for FY2024, which is 703.02% up from last year.
  • Per Select Medical Holdings' latest filing, its Cost of Revenue stood at $1.2 billion for Q3 2025, which was up 706.93% from $1.2 billion recorded in Q2 2025.
  • Select Medical Holdings' Cost of Revenue's 5-year high stood at $1.4 billion during Q1 2022, with a 5-year trough of $16.3 million in Q4 2022.
  • In the last 5 years, Select Medical Holdings' Cost of Revenue had a median value of $1.2 billion in 2024 and averaged $1.2 billion.
  • Per our database at Business Quant, Select Medical Holdings' Cost of Revenue crashed by 9883.72% in 2022 and then soared by 648570.11% in 2023.
  • Select Medical Holdings' Cost of Revenue (Quarter) stood at $1.4 billion in 2021, then tumbled by 98.84% to $16.3 million in 2022, then surged by 6485.7% to $1.1 billion in 2023, then grew by 9.41% to $1.2 billion in 2024, then grew by 3.48% to $1.2 billion in 2025.
  • Its Cost of Revenue stands at $1.2 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $1.2 billion for Q1 2025.